Encompass Health Corporation EHC
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 6.34B | 6.21B | 6.07B | 5.94B | 5.80B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.34B | 6.21B | 6.07B | 5.94B | 5.80B |
| Cost of Revenue | 3.54B | 3.48B | 3.43B | 3.37B | 3.32B |
| Gross Profit | 2.80B | 2.72B | 2.64B | 2.56B | 2.47B |
| SG&A Expenses | 313.80M | 309.90M | 306.70M | 300.50M | 287.30M |
| Depreciation & Amortization | 356.90M | 346.50M | 336.00M | 327.90M | 319.50M |
| Other Operating Expenses | 963.00M | 948.90M | 907.80M | 883.40M | 863.00M |
| Total Operating Expenses | 5.17B | 5.09B | 4.98B | 4.88B | 4.79B |
| Operating Income | 1.16B | 1.12B | 1.09B | 1.05B | 1.00B |
| Income Before Tax | 1.07B | 1.03B | 1.00B | 953.00M | 896.70M |
| Income Tax Expenses | 218.80M | 210.30M | 207.70M | 192.90M | 175.10M |
| Earnings from Continuing Operations | 847.00 | 817.60 | 795.40 | 760.10 | 721.60 |
| Earnings from Discontinued Operations | 15.30M | 15.70M | 15.40M | -1.00M | -1.40M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -217.90M | -212.30M | -201.60M | -192.90M | -179.20M |
| Net Income | 644.40M | 621.00M | 609.20M | 566.20M | 541.00M |
| EBIT | 1.16B | 1.12B | 1.09B | 1.05B | 1.00B |
| EBITDA | 1.52B | 1.46B | 1.42B | 1.38B | 1.32B |
| EPS Basic | 6.48 | 6.22 | 6.07 | 5.62 | 5.37 |
| Normalized Basic EPS | 4.45 | 4.23 | 4.14 | 4.01 | 3.80 |
| EPS Diluted | 6.41 | 6.14 | 5.99 | 5.54 | 5.29 |
| Normalized Diluted EPS | 4.39 | 4.17 | 4.07 | 3.94 | 3.73 |
| Average Basic Shares Outstanding | 396.50M | 398.70M | 400.50M | 401.80M | 401.60M |
| Average Diluted Shares Outstanding | 402.30M | 404.90M | 407.20M | 408.70M | 409.00M |
| Dividend Per Share | 0.78 | 0.76 | 0.74 | 0.72 | 0.70 |
| Payout Ratio | 11.93% | 12.11% | 12.05% | 12.56% | 12.77% |